JLK-UIA
Scope
Date
~
-
Bio & Pharma
JLK gets OK from FDA for ICH diagnosis solution
South Korea’s JLK Inc., an AI-based diagnosis solution and platform maker, said on Monday it got 501K approval from the US Food and Drug Admin...
Jan 06, 2025 (Gmt+09:00)
-
Bio & Pharma
JLK gets FDA OK for prostate cancer diagnosis AI solution
South Korea’s JLK Inc., an AI-based diagnosis solution and platform maker, announced on Monday that it got approval from the US Food and Drug ...
Jun 25, 2024 (Gmt+09:00)
-
Bio & Pharma
JLK to supply medical AI solutions in Indonesia
South Korea’s JLK Inc., an AI-based stroke care platform maker, announced on Tuesday that it signed a business agreement with medical consulti...
Apr 30, 2024 (Gmt+09:00)
-
Bio & Pharma
Korea's JLK targets AI-based stroke care market in US
South Korea’s JLK Inc., an AI-based stroke care platform maker, will go all out to build its foothold in the US this year, aiming to lift its ...
Jan 10, 2024 (Gmt+09:00)
-
Bio & Pharma
JLK supplies AI stroke solutions to Philippines
JLK Inc., South Korea's stroke diagnosis specialist company, announced on Thursday it implemented two artificial intelligence (AI) stroke diagnostic...
Nov 09, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand